Back to Agenda
Networking Reception and Poster Session
Session Chair(s)
Poster Session
United States
Comparison of Dissolution Profiles: A Statistician's Perspective
Thomas Hoffelder
Statistician
Boehringer Ingelheim Pharma Gmbh & Co. KG,Germany
Sample Size Determination in Clincal Trials with Two Time-to-Event Outcomes
Toshimitsu Hamasaki, PhD, MS
Chief at Office of Biostatistics and Data Management
National Cerebral and Cardiovascular Center, Japan
Drug Pharmacokinetics-ECG Correlation in the Dynamic Clinical Study Environment – Evaluation of Contributing Factors
Galina Bernstein, PhD
Research Scientist, PK, Scientific Affairs
INC Research
Canada
Development of Methods for Shelf-Life Determination with Large Number of Batches
Sungwoo Choi, PhD
Mathematical Statistician
FDA, United States
Some Statistical Issues in Concentration-QTc Modeling
Dalong Huang, PhD
Mathematical Statisitician
FDA, United States
Enabling Activities to Find Predictive Biomarkers
Rosalind Jane Walley, MA
Statistician
UCB Celltech, United Kingdom
Bioequivalence Evaluation of Sparse Sampling Data Using Bootstrap Resampling Method
Meiyu Shen, PhD
Mathematics Statistician, Office of Translational Sciences, CDER
FDA, United States
Using Bayesian Statistical Methods to Reduce Resources and Improve Decision Making Processes in Early Development at UCB
Foteini Strimenopoulou, PhD
Principal Statistician
UCB Pharma, United Kingdom
Statistical Considerations for Evaluating Abuse Deterrent Opioids in Human Abuse Potential Studies
Catherine Ann Mills, MSc
Principal Data Analyst
INC Research, Canada
Scopes and Utilization of PET/CT Tomographic Images in Phase I, and II Clinical Studies
Altaf Khan, MS, MSc
Biostatisticain
King Abdullah International Medical Resaerch Center, United States
Statistical Issues of Using Adaptive and Group Sequential Designs in PK Crossover Studies
Yu-Ting Weng, PhD
FDA, United States
Development of Statistical Methods for Parallelism Test of Bioassays
Cassie Dong, PhD
Mathematical Statistician, Division of Biometrics VI, OTS, CDER
FDA, United States
Statistical Approaches of the Equivalence Test Using a Function of Reference Product Varience as Margin
Cassie Dong, PhD
Mathematical Statistician, Division of Biometrics VI, OTS, CDER
FDA, United States
How Statistics can Reduce the Damage from a Fraud in Clinical Trials
Giulia Tonini, PhD
External Expert Evaluator
Menarini-Ricerche, Italy
The Roadmap of Osteogenesis Imperfecta in Athens Greece. From Child to Adulthood. An ITINERAR E
Androniki Drakou, MD, PhD
Consultant Orthopaedic Surgeon
Attikon University Hospital, Greece
Have an account?